Out of 1 analyst, 0 (0%) are recommending ZSAN as a Strong Buy, 0 (0%) are recommending ZSAN as a Buy, 1 (100%) are recommending ZSAN as a Hold, 0 (0%) are recommending ZSAN as a Sell, and 0 (0%) are recommending ZSAN as a Strong Sell. What is ZSAN’s Earnings Per Share (EPS) forecast for 2022-2022?
Similarly Who is Farmmi stock? $ 0.1247
| Close | Chg | Chg % |
|---|---|---|
| $0.1259 | -0.0054 | -4.11% |
il y a 4 jours
Why did Acasti Pharma stock drop? Acasti Pharma stock dropped from $2.18 to under $1 in a single trading session. Valentine’s Day turned out to be no sweeter for ACST stock. The stock fell further when the company posted a larger loss than expected. For the company’s 2020 fiscal third quarter, it posted a loss of 14 cents per share.
Additionally, Will zosano Pharma go up?
Zosano Pharma Corp (NASDAQ:ZSAN)
The 1 analysts offering 12-month price forecasts for Zosano Pharma Corp have a median target of 21.00, with a high estimate of 21.00 and a low estimate of 21.00. The median estimate represents a +615.50% increase from the last price of 2.94.
What is Qtrypta?
Qtrypta is an intracutaneous patch—about the size of a quarter—that uses drug-coated microneedles to deliver the well-established migraine med zolmitriptan to the bloodstream.
What kind of company is FAMI? About Farmmi Inc
Farmmi Inc is a China-based holding company. The Company, through its subsidiaries, is engaged in processing and distributing dried edible mushrooms, mainly Shiitake and Mu Er mushrooms, and trading other agricultural products.
How many shares does FAMI have? Share Statistics
| Avg Vol (3 month) 3 | 29.88M |
|---|---|
| Shares Outstanding 5 | 597.78M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 548.92M |
| % Held by Insiders 1 | 1.59% |
What is NAKD stock? Cenntro Electric Group Ltd (NAKD)
Will Acasti Pharma stock go up?
The Wall Street analyst predicted that ACASTI PHARMA’s share price could reach $6.00 by Dec 22, 2022. The average ACASTI PHARMA stock price prediction forecasts a potential upside of 421.74% from the current ACST share price of $1.15.
Is Acasti Pharma a good stock to buy? Oppenheimer is very positive about ACST and gave it a « » rating on Dec 22, 2021 . The price target was set to 1.69+52.25.
…
Predicted Opening Price for Acasti Pharma of Tuesday, April 12, 2022.
| Fair opening price April 12, 2022 | Current price |
|---|---|
| $1.13 | $1.12 (Undervalued) |
Is Acasti Pharma A Good Investment?
Acasti Pharma has received a consensus rating of Buy.
What does zosano Pharma do? Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing products where rapid administration of approved molecules with established safety and efficacy profiles may provide substantial benefit to patients, in markets where patients remain underserved by existing therapies.
What is AXS 07?
AXS-07 (meloxicam and rizatriptan) is a non-steroidal anti-inflammatory drug and triptan combination in development for the acute treatment of migraine. Meloxicam is a selective COX-2 inhibitor non-steroidal anti-inflammatory drug used in the treatment of arthritis.
Is Farmmi a Chinese company?
Farmmi Inc is a China-based holding company. The Company, through its subsidiaries, is engaged in processing and distributing dried edible mushrooms, mainly Shiitake and Mu Er mushrooms, and trading other agricultural products.
When was Farmmi founded? It also operates Farmmi Jicai, an online store that sells edible fungi products under the Forasen and Farmmi Liangpin brands.
…
Farmmi.
| Type | Public company |
|---|---|
| Founded | 2003 |
| Headquarters | Lishui , China |
| Area served | Worldwide |
| Key people | Yefang Zhang (CEO) |
Is NAKD undervalued? NAKD stock may be low-priced. But it is far from undervalued.
Is NAKD a buy or sell?
Barchart Opinion
| Composite Indicator | ||
|---|---|---|
| TrendSpotter | Sell | |
| 50 – Day Average Volume: 5,490,481 | Average: 100% Sell | |
| Long Term Indicators | ||
| 100 Day Moving Average | Sell |
• 13 janv. 2022
What will happen to NAKD stock after merger? Under the terms of the merger, Naked shareholders will receive seven shares in the new entity for every three existing NAKD shares they own. The combined company will have a market capitalization of nearly $2 billion.
Is ACST undervalued?
Valuation metrics show that Acasti Pharma, Inc. may be overvalued. Its Value Score of D indicates it would be a bad pick for value investors. The financial health and growth prospects of ACST, demonstrate its potential to underperform the market.
Will ACST reverse split? Acasti Pharma, Inc. (ACST) will effect a one-for-eight (1-8) reverse split of its common stock. The reverse stock split will become effective on Tuesday, August 31, 2021. In conjunction with the reverse split, the CUSIP number will change to 00430K873.
